Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Feagan

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's diseaseM Rosario, N L Dirks, M R Gastonguay, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2015
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trialsV Jairath, R Khanna, G Y Zou, et al.
The New England Journal of Medicine|February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group InvestigatorsB G Feagan, J Rochon, R N Fedorak, et al.
Alimentary Pharmacology & Therapeutics|September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseasesK Papamichael, T Van Stappen, V Jairath, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activityR Khanna, G Zou, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's diseaseC Ma, S J Dutton, L E Cipriano, et al.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2017
Review article: dose optimisation of infliximab for acute severe ulcerative colitisP Hindryckx, G Novak, N Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's diseaseM Rosario, N L Dirks, M R Gastonguay, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2015
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trialsV Jairath, R Khanna, G Y Zou, et al.
The New England Journal of Medicine|February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group InvestigatorsB G Feagan, J Rochon, R N Fedorak, et al.
Alimentary Pharmacology & Therapeutics|September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseasesK Papamichael, T Van Stappen, V Jairath, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activityR Khanna, G Zou, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's diseaseC Ma, S J Dutton, L E Cipriano, et al.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2017
Review article: dose optimisation of infliximab for acute severe ulcerative colitisP Hindryckx, G Novak, N Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Pageof 8